IDEXX Laboratories, Inc. (BVMF:I1DX34)

Market Cap	303.57B
Revenue (ttm)	22.21B
Net Income (ttm)	5.48B
Shares Out	n/a
EPS (ttm)	67.15
PE Ratio	55.44
Forward PE	50.04
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1
Average Volume	58
Open	777.26
Previous Close	786.34
Day's Range	777.26 - 777.26
52-Week Range	439.00 - 813.60
Beta	1.69
RSI	62.81
Earnings Date	Feb 2, 2026

About IDEXX Laboratories

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1983
• Employees: 11,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: I1DX34

Financial Performance

In 2024, IDEXX Laboratories's revenue was $3.90 billion, an increase of 6.46% compared to the previous year's $3.66 billion. Earnings were $887.87 million, an increase of 5.07%.

Financial numbers in USD